Madrigal Pharmaceuticals Inc. will participate in the TD Cowen 46th Annual Health Care Conference on March 3, 2026 at 2:30 p.m. ET, with a live webcast available at https://www.globenewswire.com/Tracker?data=ZXzyg8No52hKbSibT_5Oeb1gKkfNodO7D1ik1VX566ZxLr8LOShz3MREEG9Xp4CgXAXa0u5kQOO3WKkPSQdvPLz9yZ1-2CWliSXfccxKNm9DeyjspaPIJ6jV8O1cu8Lj53BDhLnJOZ5SukeldHkkCQ== and via the company’s Investor Relations Events page at https://www.globenewswire.com/Tracker?data=4niRYEJO3AHLiHpqSHVaic4GFXwfRHHDVxo4pvsgpsMqJ3CqP6pkXfiSSuGf9omYu9M9EXxIHwpxkbjkL7vdrzQXJgJ5uXxoW4e1YwFoALIZAKZWYJvp9yly5C1O8U92.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Madrigal Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602240800PRIMZONEFULLFEED9659539) on February 24, 2026, and is solely responsible for the information contained therein.
Comments